iasusa

Coinfections in the Setting of ART: Tuberculosis, Opportunistic Infections, and Others -- Lead: Brenda E. Crabtree Ramírez, MD 08.01.2025 34:19 ↓

Coinfections in the Setting of ART: Tuberculosis, Opportunistic Infections, and Others -- Lead: Brenda E. Crabtree Ramírez, MD by iasusa

Welcome and Introduction -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD 08.01.2025 5:57 ↓

Welcome and Introduction -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD by iasusa

Closing Remarks -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD 08.01.2025 6:25 ↓

Closing Remarks -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD by iasusa

When and What to Start -- Lead: Huldrych F. Günthard, MD 08.01.2025 39:57 ↓

When and What to Start -- Lead: Huldrych F. Günthard, MD by iasusa

Comorbidities in the Setting of ART: Focus on Cardiovascular Disease, Statins, and Weight Management -- Leads: Melanie A. Thompson, MD, and Roger J. Bedimo, MD 08.01.2025 36:11 ↓

Comorbidities in the Setting of ART: Focus on Cardiovascular Disease, Statins, and Weight Management -- Leads: Melanie A. Thompson, MD, and Roger J. Bedimo, MD by iasusa

Substance Use Disorder and HIV -- Lead: Sandra A. Springer, MD 08.01.2025 33:08 ↓

Substance Use Disorder and HIV -- Lead: Sandra A. Springer, MD by iasusa

HIV Prevention and STI Prevention -- Lead: Raphael J. Landovitz, MD 08.01.2025 43:38 ↓

HIV Prevention and STI Prevention -- Lead: Raphael J. Landovitz, MD by iasusa

Welcome and Introductions -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD 08.01.2025 4:39 ↓

Welcome and Introductions -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD by iasusa

Strategies to Reduce Cardiovascular Disease in Persons With HIV in 2024 – Where Do We Go From Here? -- Presenter: Priscilla Y. Hsue, MD 08.01.2025 45:02 ↓

Strategies to Reduce Cardiovascular Disease in Persons With HIV in 2024 – Where Do We Go From Here? -- Presenter: Priscilla Y. Hsue, MD by iasusa

A Pound of Cure: Exploring the Potential Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and Other Substance Use Treatments Beyond Opioids -- Presenter: Ellen F. Eaton, MD 08.01.2025 49:45 ↓

A Pound of Cure: Exploring the Potential Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and Other Substance Use Treatments Beyond Opioids -- Presenter: Ellen F. Eaton, MD by iasusa

Advancements in Long-Acting Drugs for HIV Treatment and Prevention, Including Emerging Therapies -- Presenter: Roy M. Gulick, MD, MPH 08.01.2025 40:02 ↓

Advancements in Long-Acting Drugs for HIV Treatment and Prevention, Including Emerging Therapies -- Presenter: Roy M. Gulick, MD, MPH by iasusa

Treating and Preventing HIV: Updates From the IAS–USA Guidelines -- Presenter: Rajesh T. Gandhi, MD 08.01.2025 50:35 ↓

Treating and Preventing HIV: Updates From the IAS–USA Guidelines -- Presenter: Rajesh T. Gandhi, MD by iasusa

Closing -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD 08.01.2025 4:19 ↓

Closing -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD by iasusa

Comprehensive Overview: Latest Guidelines for Screening and Treatment for Human Papillomavirus and Anal Cancer -- Presenter: Timothy J. Wilkin, MD, MPH 08.01.2025 45:50 ↓

Comprehensive Overview: Latest Guidelines for Screening and Treatment for Human Papillomavirus and Anal Cancer -- Presenter: Timothy J. Wilkin, MD, MPH by iasusa

Dermatologic Manifestations of HIV -- Presenter: Toby Maurer, MD 07.01.2025 47:13 ↓

Dermatologic Manifestations of HIV -- Presenter: Toby Maurer, MD by iasusa

Welcome and Introduction (Day 1) 07.01.2025 17:09 ↓

Welcome and Introduction (Day 1) by iasusa

Treatment and Prevention of Syphilis in People With HIV -- Presenter: Kimberly A. Workowski, MD 07.01.2025 44:34 ↓

Treatment and Prevention of Syphilis in People With HIV -- Presenter: Kimberly A. Workowski, MD by iasusa

HRSA Ryan White HIV/AIDS Program Updates -- Presenter: Laura W. Cheever, MD, ScM 07.01.2025 41:19 ↓

HRSA Ryan White HIV/AIDS Program Updates -- Presenter: Laura W. Cheever, MD, ScM by iasusa

‘Weighing’ the Clinical Benefits of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) -- Presenter: Suman Srinivasa, MD, MS 07.01.2025 47:24 ↓

‘Weighing’ the Clinical Benefits of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) -- Presenter: Suman Srinivasa, MD, MS by iasusa

Patient Engagement in Care: Strategies to Inform Implementation Science and Practice -- Presenter: Michael J. Mugavero, MD, MHSc 07.01.2025 47:59 ↓

Patient Engagement in Care: Strategies to Inform Implementation Science and Practice -- Presenter: Michael J. Mugavero, MD, MHSc by iasusa

New and Investigational Antiretroviral Drugs and Formulations: Transforming the Care of People with HIV -- Presenter: Rajesh T. Gandhi, MD 07.01.2025 40:15 ↓

New and Investigational Antiretroviral Drugs and Formulations: Transforming the Care of People with HIV -- Presenter: Rajesh T. Gandhi, MD by iasusa

Welcome (Day 3) 07.01.2025 10:10 ↓

Welcome (Day 3) by iasusa

Shots, Shots, Shots: Updates on Oral and Injectable Preexposure Prophylaxis -- Presenter: Hyman Scott, MD, MPH 07.01.2025 47:43 ↓

Shots, Shots, Shots: Updates on Oral and Injectable Preexposure Prophylaxis -- Presenter: Hyman Scott, MD, MPH by iasusa

HIV Care: Successfully Navigating the Transition from Pediatric to Adult Care -- Presenter: Allison L. Agwu, MD, ScM 07.01.2025 47:50 ↓

HIV Care: Successfully Navigating the Transition from Pediatric to Adult Care -- Presenter: Allison L. Agwu, MD, ScM by iasusa

Top 10 Questions to the NCCC Warmline: What’s Coming Up for Providers Across the Country? -- Presenter: Carolyn Chu, MD, MSc 07.01.2025 41:36 ↓

Top 10 Questions to the NCCC Warmline: What’s Coming Up for Providers Across the Country? -- Presenter: Carolyn Chu, MD, MSc by iasusa